Jason A. Corsa - Concepedia

Author

Jason A. Corsa

Bristol-Myers Squibb (United States)

Also Known As

Corsa, J.A., J CORSA, J. Corsa, J.A. Corsa, Jason A. Corsa, Jason Corsa

Publications

566

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)

About

Jason A. Corsa is an author at Bristol-Myers Squibb (United States) specializing in medicine, drug discovery, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	109
2	Natural Sciences	5	5	75
3	Biochemistry	4	4	65
4	Health Sciences	1	1	19
5	Social Sciences	1	1	62

Jason A. Corsa

Publications

558

Citations

H-Index

Page 1

	Year	Citations
Dynamics of β-Amyloid Reductions in Brain, Cerebrospinal Fluid, and Plasma of β-Amyloid Precursor Protein Transgenic Mice Treated with a γ-Secretase Inhibitor Donna M. Barten, Valerie Guss, Jason A. Corsa, Journal of Pharmacology and Experimental Therapeutics	2005	159
An Assessment of the Effects of Serotonin 6 (5-HT6) Receptor Antagonists in Rodent Models of Learning Mark D. Lindner, Donald B. Hodges, John B. Hogan, Journal of Pharmacology and Experimental Therapeutics	2003	99
The Amyloid-β Rise and γ-Secretase Inhibitor Potency Depend on the Level of Substrate Expression Catherine R. Burton, Jere E. Meredith, Donna M. Barten, Journal of Biological Chemistry	2008	66
Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping Mark D. Lindner, John B. Hogan, Donald B. Hodges, Psychopharmacology Cognitive ScienceScopolamine-induced DeficitsPsychopharmacologyMemoryNeuroscience	2006	62
P-Glycoprotein Efflux and Other Factors Limit Brain Amyloid β Reduction by β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitors in Mice Jere E. Meredith, Lorin A. Thompson, Jeremy H. Toyn, Journal of Pharmacology and Experimental Therapeutics	2008	41
Discovery of (S)-2-((S)-2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-((S,Z)-3-methyl-4-oxo-4,5-dihydro-3H-benzo[d][1,2]diazepin-5-yl)propanamide (BMS-433796): A γ-secretase inhibitor with Aβ lowering activity in a transgenic mouse model of Alzheimer’s disease C. V. C. Prasad, Ming Zheng, Shikha Vig, Bioorganic & Medicinal Chemistry Letters Neurochemical BiomarkersTransgenic Mouse ModelAlzheimer ’Pharmaceutical ChemistryMolecular Pharmacology	2007	30
2,3-Benzodiazepin-1,4-diones as peptidomimetic inhibitors of γ-secretase C. V. C. Prasad, Shikha Vig, David W. Smith, Bioorganic & Medicinal Chemistry Letters Peptidomimetic InhibitorsMedicinePharmacologyInhibitory ActivityDrug Discovery	2004	26
Soluble Aβ and cognitive function in aged F-344 rats and Tg2576 mice Mark D. Lindner, John B. Hogan, R. M. Krause, Behavioural Brain Research F-344 RatsNeurodegenerative DiseasesAgingPhysiologyDegenerative Pathology	2006	19
Amino-caprolactam derivatives as γ-secretase inhibitors Michael F. Parker, Joanne J. Bronson, Donna M. Barten, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	2007	13
Nitrogen-appended N-alkylsulfonamides as inhibitors of γ-secretase Carl P. Bergstrom, C.P. Sloan, Henry H. Wang, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryNitrogen-appended N-alkylsulfonamidesNatural SciencesChemical Biology	2007	11

Page 1